Eli Lilly in the first quarter net profit of 1.25 billion U.S. dollars fell 5% year on year – Eli Lilly Pharmaceutical – pharmaceutical industries
Beijing on April 19 evening news, according to foreign media reports today, Eli Lilly Pharmacy (EliLilly & Co) today announced first quarter fiscal 2010 earnings. The report shows that U.S. health care system as a comprehensive reform bill of costs, Eli Lilly first-quarter profit fell 5%.
Report shows the first quarter of Lilly Pharmaceuticals net profit 1.25 billion, earnings per share of 1.13 U.S. dollars, the performance is less than a year ago. The first quarter of fiscal 2009, Eli Lilly net profit was 13.1 billion U.S. dollars, earnings per share of 1.20 U.S. dollars. Excluding special items, Eli Lilly first quarter earnings per share of 1.18 U.S. dollars, exceeding analyst expectations. Bloomberg News survey of 15 analysts surveyed had expected on average, Eli Lilly earnings per share for the first quarter of 1.11 U.S. dollars.
Eli Lilly said the U.S. president Barack? Obama (BarackObama) proposed a comprehensive reform bill health care system, has been approved in March, resulting in the company's first quarter earnings per share decreased by 12 cents. Eli Lilly first-quarter revenue of 54.9 billion U.S. dollars, up 8.7% over the same period last year but less than analysts expected. Bloomberg News survey of 12 analysts surveyed had on average expected the first quarter of Lilly's pharmaceutical revenue of 5.59 billion U.S. dollars.
Investment company LeerinkSwann & Co analyst Seamus? Fernandez (SeamusFernandez) said, according to the reform bill has been approved for the elderly and disabled Medicare health care programs and Medicaid for the poor program, and Drugs The manufacturer's revenue will be the industry discounts.
Eli Lilly in the first quarter due to revenue growth, the company's best-selling antipsychotic Zyprexa Sell Growth; In addition, antidepressant Cymbalta and the treatment of malignant pleural mesothelioma drug Alimta (Alimta) in sales on the rise. Zyprexa and Cymbalta patents respectively in 2011 and 2013.
Barclays Capital (BarclaysCapital) analyst Tony? Butler (TonyButler) said he thought the ceremony would not introduce new products to the pharmaceutical patent expiration to make up for the downward trend will lead to sales. Eli Lilly in the first quarter effective tax rate was 26.9%, 22% higher than the same period last year, and Butler had expected 23.5%.
Eli Lilly forecast adjusted by special items, Eli Lilly earnings per share for fiscal year 2010 was 4.40 U.S. dollars to 4.55 U.S. dollars, lower than the company's January forecast of 4.65 U.S. dollars to 4.85 U.S. dollars, when the company health care system does not take into account the impact of a comprehensive reform bill. Bloomberg News survey of 12 analysts surveyed on average expect fiscal year 2010, Eli Lilly earnings per share were 4.75 U.S. dollars. Eli Lilly also predicted that the bill would cut last year, about 35 cents per share, and revenue reduction of 350 million U.S. dollars to 400 million U.S. dollars.
I am a professional editor from Hardware Wholesale,
and my work is to promote a free online trade platform.
http://www.hardware-wholesale.com/ contain a great deal of information about
ceramic pool tiles , ceramic border tiles
welcome to visit!
Processing your request, Please wait....
